MAPT and Alzheimer disease: The APPxhTau rats also demonstrated to accumulate Sarkosyl-insoluble ptau Thr231, a tau phosphorylated site implicated in early stages of AD [7, 8, 43], without developing overt tau neurofibrillary inclusions (NFT’s).